Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.
暂无分享,去创建一个
[1] E. Jaffe. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .
[2] E. Campo,et al. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. , 2003, Blood.
[3] H. Grabsch,et al. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer—association with tumour cell proliferation , 2003, The Journal of pathology.
[4] M. Oren,et al. Cell Cycle Regulation and p53 Activation by Protein Phosphatase 2Cα* , 2003, The Journal of Biological Chemistry.
[5] S. de Vos,et al. Cell Cycle Alterations in the Blastoid Variant of Mantle Cell Lymphoma (MCL-BV) as Detected by Gene Expression Profiling of Mantle Cell Lymphoma (MCL) and MCL-BV , 2003, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[6] L. Staudt,et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.
[7] A. Ferrer,et al. Abnormal expression of apoptosis‐related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma , 2003, British journal of haematology.
[8] K. Franssila,et al. Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma. , 2003, European journal of cancer.
[9] T. Kapoor,et al. hTPX2 Is Required for Normal Spindle Morphology and Centrosome Integrity during Vertebrate Cell Division , 2002, Current Biology.
[10] B. O’Malley,et al. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1 , 2002, The Journal of Steroid Biochemistry and Molecular Biology.
[11] J. Kere,et al. Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma , 2002, British journal of haematology.
[12] T. Kohwi-Shigematsu,et al. SATB1 targets chromatin remodelling to regulate genes over long distances , 2002, Nature.
[13] E. Nigg,et al. Role of Hec1 in Spindle Checkpoint Signaling and Kinetochore Recruitment of Mad1/Mad2 , 2002, Science.
[14] R. Poon,et al. Cyclin F Is Degraded during G2-M by Mechanisms Fundamentally Different from Other Cyclins* , 2002, The Journal of Biological Chemistry.
[15] D. Fishman,et al. Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. , 2002, Cancer research.
[16] J. Bjerner,et al. Serum Levels of Soluble Transferrin Receptor Correlate with Severity of Disease but Not with Iron Stores in Patients with Malignant Lymphomas , 2002, Tumor Biology.
[17] M. Ehinger,et al. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. , 2002, Cancer research.
[18] J. C. Schmitz,et al. Thymidylate synthase as a translational regulator of cellular gene expression. , 2002, Biochimica et biophysica acta.
[19] K. Franssila,et al. Ki‐67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma , 2002, European journal of haematology.
[20] J. Labat-Robert,et al. Fibronectin in malignancy. , 2002, Seminars in cancer biology.
[21] U. Hübscher,et al. The 3′–5′ exonucleases , 2002, Nature Reviews Molecular Cell Biology.
[22] D. Richardson,et al. The iron metabolism of neoplastic cells: alterations that facilitate proliferation? , 2002, Critical reviews in oncology/hematology.
[23] A. Nakagawara,et al. HMGB1 and HMGB2 Cell-specifically Down-regulate the p53- and p73-dependent Sequence-specific Transactivation from the Human Bax Gene Promoter* , 2002, The Journal of Biological Chemistry.
[24] J. Merchant,et al. ZBP-89 Promotes Growth Arrest through Stabilization of p53 , 2001, Molecular and Cellular Biology.
[25] S. Alkan,et al. Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma. , 2000, Archives of pathology & laboratory medicine.
[26] L. Resar,et al. HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene , 2000, Molecular and Cellular Biology.
[27] W. Chan,et al. Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study Group , 2000, American journal of hematology.
[28] M. Seto,et al. Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. , 2000, Blood.
[29] Paul J. Kurtin. Mantle cell lymphoma. , 1998, Advances in anatomic pathology.
[30] G. Lyons,et al. Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. , 1998, Molecular immunology.
[31] W. Benedict,et al. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] F. Bosch,et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. , 1996, Blood.
[33] A. Porwit,et al. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell‐derived non‐Hodgkin's lymphomas , 1996, Cancer.
[34] T. Lister,et al. Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.
[35] S. Elledge,et al. Human cyclin F. , 1994, The EMBO journal.
[36] H. Lovec,et al. Cyclin D1/bcl‐1 cooperates with myc genes in the generation of B‐cell lymphoma in transgenic mice. , 1994, The EMBO journal.
[37] M. V. van Oers,et al. Measurement of proliferation indices in non Hodgkin's lymphoma--is it useful? , 1992, Leukemia & lymphoma.
[38] E. Jaffe,et al. Lymphocytic Lymphoma of Intermediate Differentiation: Morphologic and Immunophenotypic Spectrum and Clinical Correlations , 1990, The American journal of surgical pathology.
[39] H. Varmus,et al. Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells , 1987, Molecular and cellular biology.
[40] S. Swerdlow,et al. From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. , 2002, Human pathology.
[41] E. Campo,et al. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. , 1997, Blood.